Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,731 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lymphoproliferative Disorder in an Esophageal Cancer Patient Treated with Pembrolizumab.
Matsumura T, Tsuchihashi K, Yamamoto T, Jinnouchi F, Kusano W, Kusumoto Y, Arimizu K, Ohmura H, Kuma Y, Moriyama S, Yamaguchi K, Ito M, Isobe T, Ariyama H, Oda Y, Akashi K, Baba E. Matsumura T, et al. Among authors: yamaguchi k. Intern Med. 2024 Oct 18. doi: 10.2169/internalmedicine.3743-24. Online ahead of print. Intern Med. 2024. PMID: 39428537 Free article.
Spatial dynamics of CD39+CD8+ exhausted T cell reveal tertiary lymphoid structures-mediated response to PD-1 blockade in esophageal cancer.
Tanoue K, Ohmura H, Uehara K, Ito M, Yamaguchi K, Tsuchihashi K, Shinohara Y, Lu P, Tamura S, Shimokawa H, Isobe T, Ariyama H, Shibata Y, Tanaka R, Kusaba H, Esaki T, Mitsugi K, Kiyozawa D, Iwasaki T, Yamamoto H, Oda Y, Akashi K, Baba E. Tanoue K, et al. Among authors: yamaguchi k. Nat Commun. 2024 Oct 19;15(1):9033. doi: 10.1038/s41467-024-53262-w. Nat Commun. 2024. PMID: 39426955 Free PMC article.
Impact of Genomic Alterations on Efficacy of Trastuzumab Deruxtecan Against Human Epidermal Growth Factor Receptor-2-Positive Advanced Gastric Cancer.
Yamaguchi K, Ito M, Isobe T, Koreishi S, Taguchi R, Uehara K, Ueno S, Imajima T, Kitazono T, Tsuchihashi K, Ohmura H, Yoshihiro T, Tanoue K, Nishiyori S, Iwama E, Maeda T, Akashi K, Baba E. Yamaguchi K, et al. JCO Precis Oncol. 2024 May;8:e2300681. doi: 10.1200/PO.23.00681. JCO Precis Oncol. 2024. PMID: 38748981
Clinical significance of cachexia index determined by bioelectrical impedance analysis in patients with gastrointestinal cancer.
Ohara T, Iwai N, Oka K, Okabe K, Sakai H, Tsuji T, Okuda T, Sakagami J, Kagawa K, Doi T, Inoue K, Dohi O, Yoshida N, Yamaguchi K, Moriguchi M, Uchiyama K, Ishikawa T, Takagi T, Konishi H, Itoh Y. Ohara T, et al. Among authors: yamaguchi k. Oncol Lett. 2024 Dec 31;29(3):114. doi: 10.3892/ol.2024.14860. eCollection 2025 Mar. Oncol Lett. 2024. PMID: 39802313 Free PMC article.
Comparative Outcomes of Supera Interwoven Nitinol Versus Eluvia Fluoropolymer-Based Drug-Eluting Stents for the Treatment of Severely Calcified Femoropopliteal Artery Lesions: Results of the ELDORADO Study.
Yanagiuchi T, Tokuda T, Yoshioka N, Kojima S, Tanaka A, Takei T, Ogata K, Yamaguchi K, Nakama T, Yokoi H; LEADers PAD investigators. Yanagiuchi T, et al. Among authors: yamaguchi k. Catheter Cardiovasc Interv. 2025 Jan 8. doi: 10.1002/ccd.31409. Online ahead of print. Catheter Cardiovasc Interv. 2025. PMID: 39780368
Prognostic significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio in uterine carcinosarcoma.
Sakurai A, Yamaguchi K, Ishida K, Horikawa N, Kawai E, Kotani Y, Yoshida T, Kishimoto N, Tatsumi K, Okudate M, Iemura Y, Taga Y, Aki M, Ando Y, Yanai A, Yamanoi K, Taki M, Murakami R, Hamanishi J, Mandai M. Sakurai A, et al. Among authors: yamaguchi k. Int J Clin Oncol. 2025 Jan 8. doi: 10.1007/s10147-024-02687-w. Online ahead of print. Int J Clin Oncol. 2025. PMID: 39779654
7,731 results